Article

Deciphering the impact of Mutations in the RBD of the Omicron Variant (BA.2) with Medicinal compound to disrupt the RBD-hACE2 complex using computational approaches

2022-11-21

Abstract excerpt

<title>Abstract</title><p>Human health and the economy have been greatly affected by COVID-19 emergence, that originated from SARS-CoV-2. Just after the very first case of COVID-19 emerged, a number of variants have been reported with severe risk of reinfection and evading immunity. Overall, 30 mutations in the spike protein have been reported in SARS-CoV-2 (BA.2) variant in India and South Africa, while half amon...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d4ffaf9d-a408-5ca0-b52d-f25dcd89c572
DOI: 10.21203/rs.3.rs-2289376/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Deciphering the impact of Mutations in the RBD of the Omicron Variant (BA.2) with Medicinal compound to disrupt the RBD-hACE2 complex using computational approachesDOI 10.21203/rs.3.rs-2289376/v1Read

The Omicron (B.1.1.529) variant of SARS-CoV-2 binds to the hACE2 receptor more strongly and escapes the antibody response: Insights from structural and simulation dataSemantic proximity Read

A hijack mechanism of Indian SARS-CoV-2 isolates for relapsing contemporary antiviral therapeutics.Semantic proximity Read

A novel consensus‐based computational pipeline for screening of antibody therapeutics for efficacy against SARS‐CoV‐2 variants of concern including Omicron variantSemantic proximity Read

Computational studies on the interaction of SARS-CoV-2 Omicron SGp RBD with human receptor ACE2, limonin and glycyrrhizic acid.Semantic proximity Read

Identification of promising high-affinity inhibitors of SARS-CoV-2 main protease from African Natural Products Databases by Virtual ScreeningSemantic proximity Read

Integrated Docking and Enhanced Sampling Based Selection of Repurposing Drugs for SARS-CoV-2 by Targeting Host Dependent FactorsSemantic proximity Read

Insights from a computational analysis of the SARS‐CoV‐2 Omicron variant: Host–pathogen interaction, pathogenicity, and possible drug therapeuticsSemantic proximity Read

Phylogenetic analysis and In silico Screening of drug targets for ACE2 in Human and Spike Glycoprotein in Sars-CoV-2 for control of COVID19Semantic proximity Read

ABBV-744 and Onalespid as Potential Inhibitors of SARS-CoV-2 main Protease Enzyme: A Promising Therapeutics in COVID-19?Semantic proximity Read

In Silico Drug Discovery: The Next Frontier in the Fight Against SARS-CoV-2Semantic proximity Read

Interaction of Drug Candidates with Various SARS-CoV‑2 Receptors: An in Silico Study to Combat COVID-19Semantic proximity Read

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodiesSemantic proximity Read